Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT

Andrew C. Dietz(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Blanche P. Alter(National Institutes of Health), Sharon A. Savage(National Cancer Institute), Carmem Bonfim(Universidade Federal do Paraná), Adrianna Vlachos(Johns Hopkins University), Roderick Skinner(Royal Victoria Infirmary), K. Scott Baker(Malaria Consortium), Jeffrey M. Lipton(Northwell Health), Jakub Tolar(University of Minnesota System), Farid Boulad(Memorial Sloan Kettering Cancer Center), Dorine Bresters(Willem-Alexander Kinderziekenhuis), John E. Wagner(Kings County Hospital Center), Parinda A. Mehta(Cincinnati Children's Hospital Medical Center), Jean Hugues Dalle(Université Paris Cité), Josu de la Fuente(Imperial College Healthcare NHS Trust), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Michael A. Pulsipher(Primary Children's Hospital)
Biology of Blood and Marrow Transplantation
May 19, 2017
10.1016/j.bbmt.2017.05.022
Cited by 61

Related Papers

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
|The Lancet|2020|1k
Hematotoxicity in Workers Exposed to Low Levels of Benzene
|Science|2004|623
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Hyponatremia among Runners in the Boston Marathon
|New England Journal of Medicine|2005|553
Ribosomal Protein L5 and L11 Mutations Are Associated with Cleft Palate and Abnormal Thumbs in Diamond-Blackfan Anemia Patients
|The American Journal of Human Genetics|2008|417